Foster City, CA, United States of America

Kathleen Dashner

This inventor holds 1 USPTO granted patent. Top assignee: Gilead Pharmasset LLC. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathleen Dashner. Retrieved from https://idiyas.com/inventor/kathleen-dashner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kathleen Dashner: Innovator in Antiviral Compounds

Introduction

Kathleen Dashner is a notable inventor based in Foster City, CA (US). She has made significant contributions to the field of antiviral compounds, particularly in the development of solid forms of these compounds. Her work is essential in the ongoing fight against viral infections.

Latest Patents

Kathleen Dashner holds 1 patent for her innovative work. The patent describes crystalline solid forms of the anti-HCV compound (S)-isopropyl 2-((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino)propanoate, referred to as Compound I. The patent also outlines processes for making and methods for using these crystalline forms, showcasing her innovative approach to antiviral research.

Career Highlights

Kathleen is currently associated with Gilead Pharmasset LLC, where she continues her research and development efforts. Her work at Gilead has positioned her as a key player in the pharmaceutical industry, particularly in the area of antiviral therapies.

Collaborations

Kathleen has collaborated with talented coworkers, including Melissa Jean Casteel and Hyuk-Jun Jung. These collaborations have further enhanced her research and contributed to the advancement of antiviral compounds.

Conclusion

Kathleen Dashner's contributions to the field of antiviral compounds are noteworthy and impactful. Her innovative work continues to play a crucial role in the development of effective antiviral therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…